Vendor review
Bopeptide Biotechnology reviews
Bopeptide Biotechnology reviews from 16 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Bopeptide Biotechnology legit? See what its vials showed.
What the lab tests show
16 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 24, 2026 | Retatrutide | 99.9 % | 31.5 mg of 30 mg (5 %) | Pass | View |
| Sep 16, 2026 | Retatrutide | 5 mg | Fail | View | |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 49.3 mg of 50 mg (-1 %) | Pass | View |
| Sep 15, 2026 | Tirzepatide | 27.3 % | 4.1 mg of 15 mg (-73 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.8 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| Aug 2, 2026 | GHK-Cu | 99.7 % | 42.5 mg of 50 mg (-15 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.9 % | 5.39 mg of 5 mg (8 %) | Pass | View |
| May 6, 2026 | GHK-Cu | 99.9 % | 40.8 mg of 50 mg (-18 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.28 % | 28.3 mg of 30 mg (-6 %) | Pass | View |
| Feb 22, 2026 | Retatrutide | 99.9 % | 19.9 mg of 20 mg (-1 %) | Pass | View |
| Jan 15, 2026 | Tirzepatide | 99.8 % | 39.4 mg of 30 mg (31 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.7 % | 31.3 mg of 30 mg (4 %) | Pass | View |
| Jan 9, 2026 | Tirzepatide | 99.95 % | 28.6 mg of 30 mg (-5 %) | Pass | View |
| Oct 3, 2025 | GHK-Cu | 99.94 % | 57.1 mg of 50 mg (14 %) | Pass | View |
| Sep 10, 2025 | Tirzepatide | 99.95 % | 5.33 mg of 5 mg (7 %) | Pass | View |
| Jul 31, 2025 | Tirzepatide | 98.903 % | 10.95 mg of 10 mg (10 %) | Pass | View |
What Bopeptide Biotechnology sells
No current listings on record.
About Bopeptide Biotechnology
Finnrick has tested 16 samples from Bopeptide Biotechnology across 3 products.